SMTL ID : 5ftq.1

Crystal structure of the ALK kinase domain in complex with Cmpd 17

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x U4W: N-[5-(3,5-DIFLUOROBENZYL)-1H-INDAZOL-3-YL]-2-[(4-HYDROXYCYCLOHEXYL)AMINO]-4-(4-METHYLPIPERAZIN-1-YL) BENZAMIDE(Non-covalent)

U4W.1: 20 residues within 4Å: Chain A: L.30, G.31, F.35, V.38, A.56, L.104, E.105, L.106, M.107, A.108, G.109, G.110, D.111, E.118, R.161, N.162, C.163, L.164, G.177, D.178 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:L.30, A:F.35, A:F.35, A:F.35, A:F.35, A:V.38, A:L.104, A:D.111, A:L.164, A:L.164 Hydrogen bonds: A:E.105, A:M.107, A:M.107 Salt bridges: A:E.118

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 5 residues within 4Å: Chain A: S.232, Y.235, P.239, P.259, K.260 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.260 Water bridges: A:S.232, A:K.260

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Menichincheri, M. et al., Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (Alk), C-Ros Oncogene 1 Kinase (Ros1), and Pan-Tropomyosin Receptor Kinases (Pan-Trks) Inhibitor. J.Med.Chem. (2016)

Release Date

2016-04-06

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence